On March 20, the 2026 China Pharmacy Annual Development Report Conference (Baiqiang Conference), hosted by China Drugstore magazine, concluded successfully in Suzhou. Widely regarded as an early-year bellwether for China’s pharmaceutical retail sector, the conference centered on the theme “A Major Discussion on Pharmacy Value” and continued to explore how retail pharmacies can reposition themselves, redefine value, and achieve sustainable, high-quality growth through its core principles of academic guidance and people-centered development. Echo Orea, a brand of Yaohai Novagen, made a striking appearance with its recombinant humanized type III collagen product portfolio. Its innovative market positioning and robust technical capabilities made it one of the most closely watched exhibitors.
Technical Strength | Genuine Collagen for Healthier Skin
Echo Orea’s standout presence at the conference is backed by formidable technical capabilities.
Parent company Yaohai Novagen has worked in biosynthesis for many years. Its mature recombinant protein R&D and manufacturing system provides Echo Orea with strong research capabilities and supports the product philosophy “Biosynthesis · Beauty, Naturally.”
Echo Orea’s core ingredient—recombinant humanized type III collagen—offers multiple advantages:
● Its amino acid sequence is identical to human collagen, allowing the skin to recognize and absorb it directly. It is non-immunogenic and offers a stronger safety profile;
● It supports skin-barrier repair, activates fibroblasts, and promotes collagen regeneration, while also playing an important role in hemostasis and wound repair;
● Clinically validated performance significantly improves wrinkles and skin elasticity, making it suitable for post-procedure repair and daily sensitive-skin care;
● It contains no non-human collagen sequences or exogenous cross-linking agents. Pharmaceutical-grade rigor helps make skincare more reassuring.
Innovation in Action | Pharmacy Skin Booster · Collagen Mask
Addressing the needs of pharmacy-based skin health, Echo Orea launched its key product—the Pharmacy Skin Booster Collagen Mask—at the Baiqiang Conference. The product brings the innovative “pharmacy skin booster” concept to life, moving professional hydration care beyond the limits of medical-aesthetic clinics.
Centered on recombinant humanized type III collagen, the collagen mask brings medical-aesthetic-grade hydration care into everyday pharmacy settings. No complex procedure is required, allowing consumers to access professional skincare conveniently at a local pharmacy. The lightweight, close-fitting sheet locks in moisture and supports efficient delivery, helping repair a compromised barrier, replenish collagen, and leave skin hydrated, luminous, firm, and refined. It is well aligned with the skincare needs of mainstream pharmacy consumers.
Channel Expansion | Pharmacy Partnerships Fully Underway
Echo Orea has already achieved important channel expansion through a strategic partnership with Nanjing Pharmaceutical Baixin Pharmacy. Its products are now available in dozens of Baixin stores across Nanjing, allowing consumers to purchase authentic collagen products and receive professional pharmacist consultation at trusted local pharmacies.
During the Baiqiang Conference, Echo Orea held in-depth discussions with several national pharmacy chains, including Nepstar, on core topics such as channel strategy, scenario-based implementation, and partnership models. These exchanges laid a strong foundation for broader nationwide pharmacy expansion and mutually beneficial cooperation.
Looking Ahead | Inviting Pharmacy Partners Nationwide to Grow Together
Echo Orea’s presence at the Baiqiang Conference marks an important step in its expansion into pharmacy-based skin health and sends a clear signal of the brand’s commitment to pharmaceutical retail channels and category upgrading. Going forward, Echo Orea will continue to center on recombinant humanized type III collagen, strengthen R&D innovation, expand its product portfolio, deepen pharmacy-channel development, and refine its channel network. We warmly invite leaders and partners from pharmacy chains nationwide to connect with us, explore the cross-sector value of “pharmacy + skincare,” break through growth bottlenecks, and lead the emerging pharmacy skin-health market together.
Company Profile: Echo Orea, a brand of Yaohai Novagen, specializes in the R&D, manufacturing, and sales of recombinant humanized type III collagen products. Built on biosynthesis technology and developed to pharmaceutical-grade standards, its professional skincare portfolio supports the transformation and upgrading of pharmacy channels.
Contact: Manager Zhou
Tel: 13903449381
Highlights from the Baiqiang Conference
ABOUT US
Biosynthesis · Beauty, Naturally
Yaohai Novagen is a biotechnology company incubated by Yaohai Biopharmaceutical, a national-level specialized and innovative enterprise, and is dedicated to providing science-based solutions for problem skin. Building on its parent company’s expertise in microbial expression systems and synthetic biology, the company has established an integrated R&D, manufacturing, and sales platform. Its brand Echo Orea provides problem skin with effective solutions rooted in science and supported by professional validation, with a focus on the development and commercialization of bioactive ingredients such as recombinant collagen. Pharmaceutical-grade rigor is applied throughout the skincare development process, with an emphasis on evidence-based efficacy rather than concept-driven formulation. R&D innovation, research-manufacturing, and user research bases in Beijing, Taizhou, and Nanjing create a complete loop from technical insight to user needs, helping more people achieve confident, healthy, and natural beauty. By integrating pharmaceutical expertise, advanced ingredient technology, and professional pharmacy channels, Echo Orea has also established a distinctive model of co-creation between medical and research professionals.
